The Need for More Time in Movement Disorder Care: Temitope Lawal, MD
The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about the need for clinicians to have more time with patients in clinical practice, particularly with those with chronic diseases. [WATCH TIME: 2 minutes]
Drawing From Experience When Treating Parkinson Disease: Temitope Lawal, MD
The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about how his experience as a caregiver shapes his perspective as a doctor in care for those with movement disorders. [WATCH TIME: 3 minutes]
Working With Interdisciplinary Teams in Movement Disorders: Temitope Lawal, MD
The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center shared his experiences engaging with a diverse community of clinicians at the ATMRD Congress and in clinical practice. [WATCH TIME: 2 minutes]
Understanding Disorders of Consciousness Associated With Severe COVID-19
David Fischer, MD, neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital, outlined findings from a recent study that evaluated hospitalized patients with COVID-19 who were not regaining consciousness.
Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD
The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]
Disorders of Consciousness and COVID-19: David Fischer, MD
The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital discussed findings from a recent study that evaluated patients with COVID-19 and disorders of consciousness. [WATCH TIME: 3 minutes]
NeuroVoices: Aarushi Suneja, MD, and Zubair Ahmed, MD, on Improving Migraine Treatment Optimization
The duo from Cleveland Clinic stressed the reasons for conducting real-world data assessing migraine treatments and why it can lead to the ultimate goal of treatment optimization.
Nerve Blocks for the Treatment of COVID-19 Headache: Aarushi Suneja, MD
The headache fellow at Cleveland Clinic outlined the design and reasoning for a new study assessing nerve blocks to treat COVID-19 headache.
Improving Use of Telemedicine in Minority Communities: Aarushi Suneja, MD; Zubair Ahmed, MD
The duo from Cleveland Clinic discussed their presentation from AHS 2021 regarding the effects of COVID-19 on access to telemedicine visits among minorities.
NeuroVoices: Aarushi Suneja, MD, and Zubair Ahmed, MD, on Knowledge Gaps With COVID-19 Headaches
The duo from Cleveland Clinic addressed several of their research projects presented at AHS 2021 that covered a range of COVID-19 related topics, including the unknowns about associated headaches.
Neurology Trainees Report Alarming Lack of SUDEP Knowledge
About half of national (49%) and international trainees rarely or never counseled patients on sudden death in epilepsy, despite the majority reporting seeing at least 45 patients with the condition during their training.
Investigating Disparities in Post-Stroke Rehabilitation
Sana Somani, MD, MBBS, vascular neurology fellow at the University of Maryland Medical Center, discussed her research into disparities in post-stroke care.
Understanding Disparities in Stroke Care: Sana Somani, MD, MBBS
The vascular neurology fellow at the University of Maryland Medical Center discussed her study’s findings as well as further research she would like to conduct.
Disparities in Stroke Rehabilitation: Sana Somani, MD, MBBS
The vascular neurology fellow at the University of Maryland Medical Center discussed findings that African American women had the lowest functional performance in stroke rehabilitation.
7-Tesla MRI Use in Research: Jemima Akinsanya, DO, and Daniel Reich, MD, PhD
The duo from the National Institutes of Health discussed the advantages of the ultra-high resolution imaging technology in research.
Studies of Anakinra and Tolebrutinib in MS Paramagnetic Rim Lesions: Jemima Akinsanya, DO
The Neuroimmunology Clinical Fellow at the National Institutes of Health discussed the evaluations of 2 therapies in multiple sclerosis that she is partaking in.
Investigating Causes of CNS Demyelination: Spencer Hutto, MD
The fellow of autoimmune neurology at Massachusetts General Hospital discussed the need for follow-up with patients long-term after TNFα inhibitor treatment.
High Rates of MS Relapse after TNFα Inhibitor Discontinuation: Spencer Hutto, MD
The fellow of autoimmune neurology at Massachusetts General Hospital discusses the ongoing question about whether the demyelination is an unmasking of disease or consequence of the treatment.
Investigating TNFα Inhibition and CNS Demyelination: Spencer Hutto, MD
The fellow of autoimmune neurology at Massachusetts General Hospital discussed the analysis his team conducted to clarify the known associations.
Health-Deficit Accumulation Affects Risk for Mild Cognitive Impairment, Dementia
Frailty index score can identify patients at risk for cognitive dysfunction and might be an important marker with potential prognostic value.
Davide Valeriani, PhD: Using the DystoniaNet Platform for Dystonia Diagnosis
The postdoctoral research fellow in the Dystonia and Speech Motor Control Laboratory at Mass Eye and Ear spoke to the clinical translation of the AI-based DystoniaNet tool.
Leah Croll, MD: Importance of Mental Health of Clinicians During COVID-19 Pandemic
The neurology resident at NYU Langone shared her thoughts on the need for publication of clinician-based data and why maintaining a high level of mental health remains a top priority during the COVID-19 pandemic.
Neurology Residency Training During a Pandemic
In part 2 of this interview, Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, describes how her resident program experience was impacted by the pandemic.
The Psychosocial Impact of COVID-19 in Neurology Departments
Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, shares details from her study on the psychosocial impact on physicians and her first-hand experience.
Leah Croll, MD: Psychosocial Implications of COVID-19 on Doctors
The neurology resident at NYU Langone described psychosocial implications that physicians faced during the COVID-19 pandemic and the toll it takes on them.
Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.
Q&A: Genetic Ancestry and Alzheimer Disease Risk
Katrina Celis, MD, a postdoctoral fellow at the University of Miami Miller School of Medicine, discussed how ancestral genetics can play a key role in Alzheimer disease risk.
Katrina Celis, MD: Ancestral Genetics and the Impact on Alzheimer Disease Risk
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed her study presented at AAIC 2020 that examined Alzheimer risk associated with APOE ε4 in different genetic populations.
Fred Cohen, MD: OnabotulinumtoxinA and CGRP Combination Treatment
The internal medicine resident physician at Montefiore Health System provided an overview of the study he and colleagues conducted on patients using onabotulinumtoxinA and CGRP agents in tandem.
Episode 12: Masculinity and Multiple Sclerosis
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Bryan Davis, PsyD, MS.
2 Clarke Drive Cranbury, NJ 08512